Literature DB >> 16697853

Laparoscopic renal denervation and nephropexy for autosomal dominant polycystic kidney disease related pain in adolescents.

Matthew Resnick1, Andy Y Chang, Pasquale Casale.   

Abstract

PURPOSE: We present our initial experience with laparoscopic renal denervation and nephropexy for ADPKD related pain in the adolescent population.
MATERIALS AND METHODS: Four patients 15 to 19 years old previously diagnosed with ADPKD presented with chronic pain refractory to narcotic analgesics. These 4 patients underwent laparoscopic renal denervation of 5 kidneys.
RESULTS: Mean operative time was 136 minutes and mean hospital stay was 2.75 days. All patients were pain-free at discharge home and remained pain-free at a mean followup of 11.5 months.
CONCLUSIONS: We believe that laparoscopic renal denervation plus nephropexy is a promising option for uncontrolled ADPKD related pain in the adolescent population.

Entities:  

Mesh:

Year:  2006        PMID: 16697853     DOI: 10.1016/S0022-5347(06)00336-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

Review 1.  Laparoscopic renal surgery for benign disease.

Authors:  Joseph C Liao; Alberto Breda; Peter G Schulam
Journal:  Curr Urol Rep       Date:  2007-01       Impact factor: 3.092

Review 2.  Evaluation and management of pain in autosomal dominant polycystic kidney disease.

Authors:  Marie C Hogan; Suzanne M Norby
Journal:  Adv Chronic Kidney Dis       Date:  2010-05       Impact factor: 3.620

Review 3.  A stepwise approach for effective management of chronic pain in autosomal-dominant polycystic kidney disease.

Authors:  Niek F Casteleijn; Folkert W Visser; Joost P H Drenth; Tom J G Gevers; Gerbrand J Groen; Marie C Hogan; Ron T Gansevoort
Journal:  Nephrol Dial Transplant       Date:  2014-09       Impact factor: 5.992

4.  Which Stage of ADPKD Is More Appropriate for Decortication? A Retrospective Study of 137 Patients from a Single Clinic.

Authors:  Xiaoqiang Qian; Xujun Sheng; Ruipeng Li; Hailong Liu; Xiangjie Kong; Liujian Duan; Jun Qi
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.